Evolus, Inc. (EOLS) Income Statement
EOLS 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsEOLS revenue and net income
Where EOLS's revenue goes
2025Each bar shows an amount and its share of revenue. EOLS kept −17.4% of revenue as net income.
EOLS profit margins
EOLS growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +11.6% | +26.0% | +39.4% | — |
| Gross profit | +5.7% | +29.0% | +38.2% | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
EOLS quarterly EPS vs estimates
Evolus beat the analyst EPS estimate in 3 of the last 8 quarters. Next report: November 4, 2026 (estimate $-0.14).
EOLS income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $297.2M | $266.3M | $202.1M | $148.6M | $99.7M | $56.5M | $34.9M | $0 | $0 | $0 |
| Cost of revenue | $104.4M | $84.0M | $61.6M | $58.8M | $43.5M | $18.3M | $8.0M | $0 | $218,000 | $326,000 |
| Gross profit | $192.8M | $182.3M | $140.5M | $89.8M | $56.1M | $38.2M | $26.9M | $0 | −$218,000 | −$326,000 |
| Research & development | $9.6M | $9.2M | $15.4M | $6.7M | $2.1M | $1.7M | $4.0M | $6.5M | $6.7M | $12.6M |
| Sales, general & admin | $220.8M | $198.0M | $164.9M | $141.8M | $118.4M | $98.2M | $29.1M | $29.1M | $4.8M | $7.0M |
| Total operating expenses | $230.4M | $216.7M | $189.8M | $155.1M | $100.5M | $191.3M | $125.9M | $35.6M | $11.7M | $20.0M |
| Operating income | −$37.6M | −$34.4M | −$49.2M | −$65.3M | −$44.4M | −$153.1M | −$98.9M | −$46.1M | −$11.7M | −$20.0M |
| Interest income | $1.9M | $3.3M | $860,000 | $119,000 | $1,000 | $635,000 | $1.8M | $203,000 | — | — |
| Interest expense | $19.7M | $18.7M | $13.8M | $9.1M | $1.4M | $10.5M | $8.0M | $863,000 | $0 | $0 |
| Income before taxes | −$51.0M | −$49.8M | −$61.5M | −$74.3M | −$46.8M | −$162.9M | −$105.1M | −$46.8M | −$11.7M | −$20.0M |
| Income taxes | $677,000 | $664,000 | $176,000 | $95,000 | $42,000 | $77,000 | −$15.0M | $65,000 | −$7.3M | $93,000 |
| Net income | −$51.6M | −$50.4M | −$61.7M | −$74.4M | −$46.8M | −$163.0M | −$90.0M | −$46.9M | −$4.5M | −$20.1M |
| EBITDA | −$22.5M | −$25.0M | −$41.8M | −$53.1M | −$39.1M | −$144.8M | −$92.1M | −$45.9M | −$11.5M | −$19.6M |
| EPS (diluted) | −$0.62 | −$0.34 | −$0.69 | −$0.97 | −$0.91 | −$1.95 | −$3.61 | −$1.49 | −$0.98 | −$1.08 |
| Gross margin | 64.9% | 68.5% | 69.5% | 60.4% | 56.3% | 67.6% | 77.1% | — | — | — |
| Operating margin | −12.7% | −12.9% | −24.4% | −44.0% | −44.6% | −270.7% | −283.3% | — | — | — |
| Net margin | −17.4% | −18.9% | −30.5% | −50.1% | −47.0% | −288.3% | −257.8% | — | — | — |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $84.1M | $73.1M | $90.3M | $69.0M | $69.4M | $68.5M | $78.9M | $61.1M | $66.9M | $59.3M | $61.0M | $50.0M |
| Cost of revenue | $26.9M | $25.8M | $31.0M | $23.1M | $24.1M | $21.9M | $28.6M | $18.2M | $19.8M | $18.8M | $22.2M | $15.4M |
| Gross profit | $57.2M | $47.4M | $59.3M | $45.8M | $45.3M | $46.7M | $50.3M | $42.9M | $47.1M | $40.5M | $38.8M | $34.6M |
| Research & development | $1.9M | $2.2M | $3.5M | $2.0M | $1.8M | $2.2M | $2.4M | $2.3M | $2.4M | $2.1M | $6.8M | $1.6M |
| Sales, general & admin | $57.1M | $52.0M | $54.7M | $52.8M | $56.7M | $56.6M | $50.2M | $52.5M | $50.2M | $45.1M | $35.6M | $43.3M |
| Total operating expenses | $61.7M | $54.2M | $59.6M | $57.3M | $55.5M | $61.8M | $52.7M | $58.3M | $54.8M | $49.4M | $47.4M | $48.0M |
| Operating income | −$4.5M | −$6.9M | −$291,000 | −$11.5M | −$10.2M | −$15.2M | −$2.3M | −$15.5M | −$7.7M | −$8.9M | −$8.6M | −$13.4M |
| Interest income | $296,000 | $285,000 | $263,000 | $479,000 | $479,000 | $710,000 | $789,000 | $928,000 | $1.0M | $517,000 | $291,000 | $306,000 |
| Interest expense | $4.2M | $4.0M | $4.0M | $4.1M | $7.2M | $4.4M | $4.6M | $4.8M | $4.7M | $4.7M | $4.1M | $3.8M |
| Income before taxes | −$8.2M | −$10.4M | $515,000 | −$15.6M | −$17.1M | −$18.8M | −$6.4M | −$19.0M | −$11.3M | −$13.1M | −$11.7M | −$16.9M |
| Income taxes | −$154,000 | $256,000 | $385,000 | $167,000 | $53,000 | $72,000 | $440,000 | $134,000 | $43,000 | $47,000 | $106,000 | $24,000 |
| Net income | −$8.1M | −$10.7M | $130,000 | −$15.7M | −$17.1M | −$18.9M | −$6.8M | −$19.2M | −$11.3M | −$13.1M | −$11.8M | −$16.9M |
| EBITDA | −$1.3M | −$3.8M | $7.1M | −$9.2M | −$7.8M | −$12.6M | $863,000 | −$13.0M | −$5.0M | −$6.8M | −$3.6M | −$11.6M |
| EPS (diluted) | −$0.09 | −$0.05 | $0.01 | −$0.20 | −$0.26 | −$0.17 | $0.01 | −$0.18 | −$0.06 | −$0.11 | −$0.12 | −$0.18 |
| Gross margin | 68.0% | 64.8% | 65.7% | 66.5% | 65.3% | 68.1% | 63.8% | 70.2% | 70.3% | 68.3% | 63.6% | 69.1% |
| Operating margin | −5.4% | −9.4% | −0.3% | −16.7% | −14.7% | −22.1% | −2.9% | −25.3% | −11.5% | −15.0% | −14.2% | −26.9% |
| Net margin | −9.6% | −14.6% | 0.1% | −22.8% | −24.7% | −27.6% | −8.6% | −31.4% | −17.0% | −22.1% | −19.4% | −33.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in EOLS's financial statements (latest annual report filed March 3, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
EOLS financial results
In fiscal year 2025 (ended December 31, 2025), Evolus reported revenue of $297.2 million, up 11.6% from the year before. It had a net loss of $51.6 million, a net profit margin of −17.4%. Diluted earnings per share came to −$0.62. Over five years revenue grew at an average rate of 39.4% a year.
See the EOLS stock overview for the latest quote and news, or the EOLS chart for price history and technical indicators.
EOLS income statement FAQ
What is Evolus's annual revenue?
Evolus reported total revenue of $297.2 million for fiscal year 2025, which ended on December 31, 2025. That was up 11.6% from $266.3 million the previous year.
Is Evolus profitable?
No. Evolus reported a net loss of $51.6 million in fiscal 2025, a net profit margin of −17.4%; its operating margin was −12.7%.
What is Evolus's gross margin?
Evolus's gross margin was 64.9% in fiscal 2025: for every $100 of revenue, Evolus kept $65 after the direct cost of its products and services.
How much does Evolus spend on research and development?
Evolus spent $9.6 million on research and development in fiscal 2025, 3.2% of revenue.
How fast is Evolus growing?
Revenue grew 39.4% a year on average over the last five fiscal years, from $56.5 million to $297.2 million.
What are Evolus's earnings per share?
Evolus earned $-0.62 per diluted share in fiscal 2025, compared with $-0.34 a year earlier.
When will Evolus report its next earnings?
Evolus is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes.
When does Evolus's fiscal year end?
Evolus's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 3, 2026.